POZN quarterly estimate of earnings by "professional analysts" is as follows: Number of estimates 5 High estimate -$0.13 Low estimate -$0.27 Mean estimate -$0.17 I believe Pozn will beat the -$0.17 consensus and come in at -$0.15 or -$0.14 based on increasing sales of Treximet